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Abstract
Background: Recent increases in the volume and diversity of life science data and information and
an increasing emphasis on data sharing and interoperability have resulted in the creation of a large
number of biological ontologies, including the Cell Ontology (CL), designed to provide a
standardized representation of cell types for data annotation. Ontologies have been shown to have
significant benefits for computational analyses of large data sets and for automated reasoning
applications, leading to organized attempts to improve the structure and formal rigor of ontologies
to better support computation. Currently, the CL employs multiple is_a relations, defining cell
types in terms of histological, functional, and lineage properties, and the majority of definitions are
written with sufficient generality to hold across multiple species. This approach limits the CL's
utility for computation and for cross-species data integration.
Results: To enhance the CL's utility for computational analyses, we developed a method for the
ontological representation of cells and applied this method to develop a dendritic cell ontology
(DC-CL). DC-CL subtypes are delineated on the basis of surface protein expression, systematically
including both species-general and species-specific types and optimizing DC-CL for the analysis of
flow cytometry data. We avoid multiple uses of is_a by linking DC-CL terms to terms in other
ontologies via additional, formally defined relations such as has_function.
Conclusion: This approach brings benefits in the form of increased accuracy, support for
reasoning, and interoperability with other ontology resources. Accordingly, we propose our
method as a general strategy for the ontological representation of cells. DC-CL is available from
http://www.obofoundry.org.
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In the last decade, technological developments have
resulted in tremendous increases in the volumes and
diversity of the data and information that must be proc-
essed in the course of biomedical and clinical research and
practice, and researchers are under ever greater pressure
from funding agencies to share data and to take steps to
ensure that data resources are interoperable. The use of
ontologies to annotate data has proven successful in sup-
porting these goals and in providing new possibilities for
the automated processing of data and information [1-5].
This success has, in turn, resulted in the creation of a large
number of ontologies, now made available through the
Open Biological Ontologies repository [6] and through
the BioPortal of the National Center for Biomedical
Ontology [7].
More recently, ontologies have been shown to have signif-
icant benefits for the analysis of data resulting from high-
throughput technologies [8] and for automated reasoning
applications [9-12], which has led to organized attempts
to improve the structure and formal rigor of ontologies in
ways that will better support computational analysis and
reasoning [13].
To help meet the data annotation needs of model organ-
ism researchers, Bard and colleagues developed an ontol-
ogy of cell types [14] that has been widely used for the
annotation of data in genome and other biological data-
bases, including biorepository data. To enhance the CL's
utility for computational analyses, we developed a sys-
tematic approach for the ontological representation of
cells as described below, adhering to the principles out-
lined in [13].
The Cell Ontology (CL) currently contains representa-
tions of some 863 cell types, covering cell types from the
major model organisms, including prokaryotic, fungal,
animal, and plant cell types. This broad scope is accom-
plished primarily through the use of terms and definitions
that can be applied to cell types from multiple types of
organisms.
Cell types in CL are classified on the basis of a plurality of
structural, histological, functional, and lineage properties.
While some terms are provided with natural language def-
initions, most of the information in CL is conveyed
through hierarchical classifications of the cell types along
the following multiple axes of classification:
cell by organism
cell by histology
cell by function
cell by lineage
cell by nuclear number
cell by ploidy.
Each cell type within the CL is related to at least one super-
type via the is_a (subtype) relation, but most CL cell types
have multiple supertypes, and are thus classified on mul-
tiple axes, a phenonmenon referred to as 'is_a overload-
ing' [15]. CL is currently undergoing review, addressing
specifically the problems that arise from the use of multi-
ple modes of classification.
An example of the CL's use of multiple hierarchies is clas-
sification of Langerhans cell within the cell by organism and
cell by nuclear number hierarchies as a subtype of animal cell
and single nucleate cell, respectively (Figure 1). Langerhans
cell is further classified within the functional hierarchy
(Figure 1) as a subtype of:
transporting cell
professional antigen presenting cell
circulating cell
motile cell
defensive cell
phagocyte (sensu Vertebrata).
Following a path along both is_a and develops_from rela-
tions – the latter is the relation "used to code developmen-
tal lineage relationships" – reveals that Langerhans cells
are of mesodermal and hematopoietic lineage (Figure 1)
[14]. is_a and develops_from are the only relations used in
the current version of the CL.
To enhance the CL's utility for computational analyses, we
developed a systematic approach for the ontological rep-
resentation of cells that:
i) separates classification via the is_a relation from the
assertion of structural, functional, and lineage properties
by using formally defined, property-specific relations,
such as has_function
ii) systematically includes both species-neutral and spe-
cies-specific representations of cell types
iii) defines cell types on the basis of specific combinations
of surface proteins used for identification of the cells via
flow cytometry.Page 2 of 19
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The representation of Langerhans cells in the Cell OntologyFigu  1
The representation of Langerhans cells in the Cell Ontology. A portion of the Cell Ontology is shown with ovals cor-
responding to cell types defined in the ontology and arrows corresponding to relations between those cell types. Langerhans 
cell is represented by a yellow oval; blue arrows correspond to is_a relations, and orange arrows correspond to develops_from 
relations. Only a subset of Langerhans cell parent types are included in the figure.
BMC Bioinformatics 2009, 10:70 http://www.biomedcentral.com/1471-2105/10/70We have applied our method to develop an extension of
the CL, DC-CL, for dendritic cells (DC), focusing on the
DC types observed in mice and humans. The approach we
propose increases the amount and accuracy of informa-
tion contained in DC-CL, enhances its support for cross-
species data integration, and optimizes it for the analysis
of flow cytometry data.
The CL currently contains representations of six DC types:
dendritic cell
plasmacytoid dendritic cell
myeloid dendritic cell
immature myeloid dendritic cell
mature myeloid dendritic cell
Langerhans cell
which are defined on the basis of structural, functional,
and lineage characteristics. The definitions are formulated
in a highly general way to ensure broad applicability, but
unfortunately at the cost of a precise specification of cell
types. For example, plasmacytoid dendritic cell is defined as:
A dendritic cell type of distinct morphology, localiza-
tion, and surface marker expression from other den-
dritic cell types and associated with early stage
immune responses, particularly the release of physio-
logically abundant amounts of type 1 interferon in
response to infection.
In the immunological literature and research community,
the term 'dendritic cell' does not refer to a single, clearly
distinguishable cell type; rather it refers to cells from a
variety of sub-populations that have different morpholo-
gies, are distributed across different microenvironments
within the body, express different microbial receptors and
surface molecules, and different cytokines [16-18]. Cells
in the various subpopulations are referred to using a com-
mon term because they are optimized to play a particular
role in an immune response, that of priming an immune
response by stimulating naïve T cells in the T cell zones of
secondary lymphoid tissue to proliferate and execute their
effector activities, but the cells in the various sub-popula-
tions are equipped to detect different pathogens and mod-
ulate distinct classes of immune responses. The structural,
functional, and lineage similarities and differences
between these sub-populations are not yet well under-
stood, however, and their study is challenging because
they are sensitive to changes in the cells' microenviron-
ment. The subpopulations are typically characterized
using a combination of variables, including flow cytome-
try or immunohistochemistry markers, function, and ana-
tomical location, but the issue of how to define distinct
DC subtypes is still an area of active debate within the
immunology community.
We chose DCs as our case study in order to standardize the
current terminology and definitions for DC subtypes and
provide a common point of reference from which to
maintain a common representation of DCs as knowledge
about their subtypes evolves. DC-CL employs a flexible
framework, which can be amended where necessary as
knowledge advances. DC-CL can be used as a reference for
the design and description of experiments, the interpreta-
tion of experimental results, and the integration of data
from different sources, thereby facilitating progress
towards a detailed, shared understanding of DC subtypes
and/or their roles in immunity and tolerance.
Methods
To develop a general method for the ontological represen-
tation of cell types, we first identified five families of cel-
lular properties that can hold for a given cell type across
the various microenvironments in which the cell type can
be found. We identified the following five such families of
properties:
i) structural components, such as granules in the cyto-
plasm or molecules on the cell surface,
ii) functions cells of the given type perform,
iii) dispositions, such as the tendency to participate in cer-
tain types of processes,
iv) anatomical locations in which the cells are found, and
v) lineage relationships.
Among these properties, we emphasize structural compo-
nents, as these are most often used to identify cell types for
study and because their use for classification facilitates
maintenance of a single-hierarchy classification of DC
types (Figure 2). More precisely, we classify DCs by surface
protein expression. For other types of cells, other struc-
tural components may be used, as for example in the clas-
sification of eosinophils, basophils, and neutrophils,
which can be classified on the basis of types of cytoplas-
mic granules.
We next identified a set of ontology development princi-
ples designed to maximize both an ontology's utility for
computational analysis and reasoning and its interopera-
bility with existing resources. The basis of this approach is
use of relations from the OBO Foundry Relation Ontol-Page 4 of 19
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from DC-CL to other OBO Foundry ontologies (Figure 3),
as described in [13,20]. Relations in the RO are formally
defined to support automated reasoning [19]. In addition,
in constructing DC-CL we employed accepted principles
of ontology development outlined by the OBO Foundry
[13], including the use of genus-differentia definitions
[21].
We use RO relations wherever possible, and define new
relations where needed, following the approach used in
RO. Relations in RO are defined in accordance with the
distinction between types and instances [19], correspond-
ing to the standard Description Logic distinction between
A-boxes and T-boxes used within the OWL/Semantic Web
community [22]. Types are general; they are the kinds of
things that exist and are documented in scientific text-
books (e.g. human, red blood cell); instances are particu-
lar; they are the specific examples upon which
experiments are performed (e.g. J. Craig Venter, the many
red blood cells in my body). The relations between types
represented in an ontology are defined in terms of rela-
tions between the corresponding instances of those types
of the sort that can be observed in experiments. Thus, a
The representation of dendritic cell types in the Dendritic Cell Ontology (DC-CL)Figu e 2
The representation of dendritic cell types in the Dendritic Cell Ontology (DC-CL). Rectangles correspond to the 
terms for dendritic cell types represented in DC-CL, and the lines connecting the rectangles correspond to the is_a relations 
between these cell types. Black lines connect the highest-level terms in DC-CL to the Cell Ontology term leukocyte. Blue lines 
connect the DC-CL term conventional dendritic cell to the terms for its subtypes, while red lines connect these terms to the 
respective subtype terms. The green lines connect the terms CD11c- plasmacytoid dendritic cell and CD11clow plasmacytoid den-
dritic cell to the terms for their respective subtypes. Abbreviations used in the figure are: DC, dendritic cell; PDC, plasmacytoid 
dendritic cell; and LC, Langerhans Cell.
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BMC Bioinformatics 2009, 10:70 http://www.biomedcentral.com/1471-2105/10/70type-level relation R will be defined in terms of the corre-
sponding instance-level relation R as follows [where italics
indicates type-level relations, bold indicates instance-
level relations, type-level variables are denoted by upper
case (X, Y, Z, ...), and instance-level variables are denoted
by lower case italics (x, y, z, ...)]:
X stands_in_R_to Y = def for every instance x of type X, there
exists at least one instance y of type Y, such that x
stands_in_R_to y.
We use R(X, Y) and XRY to abbreviate: all Xs stand in R to
some Y. Thus, has_part(human, brain) abbreviates: every
instance of human has some instance-level part which is
an instance of brain.
Defining type-level relations in terms of all instances of X
ensures that assertions of relations between types hold
universally, i.e. XRY will hold only if all instances of X
stand in R to some instance of Y. This universality in turn
ensures the possibility of transitive reasoning by ensuring
that relations transitive at the instance level are transitive
at the type level. Thus, if R is transitive and R is defined in
terms of R and all instances of X, then, if XRY holds at time
t and YRZ holds at t, XRZ also holds at t.
Structural Components
Defining cell types in terms of surface proteins
Cell types in DC-CL are defined in terms of the proteins
and protein complexes expressed on the cell surfaces of
the corresponding instances, consistent with the charac-
terization of DC populations using surface protein expres-
sion [23]. The definitions of such types thus involve terms
representing proteins in the Protein Ontology (PRO) [24]
and protein complexes in the Gene Ontology Cellular
Component Ontology (GO CC) [25]. The reference to
proteins and protein complexes enables us to assert the
specific presence or absence of defining molecules on cells
of a given type. To make these assertions, we define the
relations has_plasma_membrane_part and
lacks_plasma_membrane_part in terms of the RO instance-
level relations has_part and instance_of and the GO CC
term plasma membrane:
We first define the instance-level relation
c has_plasma_membrane_part p at t = def there exists
some m, such that
m instance_of plasma membrane at t
c has_part m at t
The ontologies and relations referred to in the Dendritic Cell Ontology (DC-CL)Figure 3
The ontologies and relations referred to in the Dendritic Cell Ontology (DC-CL). The rectangles and ovals repre-
sent ontologies, and the arrows represent relations joining terms in the ontologies. Abbreviations for the ontology names are 
shown in normal font, and the relations used to link DC-CL to each ontology are shown in italics. The black arrow indicates 
relations used to join DC-CL terms to other DC-CL terms, while the blue arrows indicate trans-ontological relations. Ontolo-
gies and relations shown in rectangles are used to define DC-CL types, while the ontologies and relations shown in ovals are 
used to make non-classificatory assertions about DC-CL types. Abbreviations used in the figure are: GO CC, Gene Ontology 
Cellular Component Ontology; PRO, Protein Ontology; IO, Immunology Ontology; FMA, Foundational Model of Anatomy; and 
GO BP, Gene Ontology Biological Process Ontology.Page 6 of 19
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We can then define:
C has_plasma_membrane_part P = def for all c and all times
t, if c instance_of C at
t, then there exists some p such that p instance_of P and
c
has_plasma_membrane_part p at t
C lacks_plasma_membrane_part P = def for all c and all
times t, if c instance_of C at
t, then there is no p such that p instance_of P and c
has_plasma_membrane_part p at t
C has_part P is implied by C has_plasma_membrane_part P
because both the has_part and has_part relations are tran-
sitive. Neither has_plasma_membrane_part nor
has_plasma_membrane_part is transitive, however.
Note that there is an important distinction between the
two expressions:
C lacks_plasma_membrane_part P
It is not the case that C has_plasma_membrane_part P.
The former asserts that there is no instance of the type C
that has an instance of the type P as a part of its plasma
membrane; the latter asserts only that there is at least one
instance of the type C that has no instance of the type P as
part of its plasma membrane.
Using the above-defined relations, definitions for DC-CL
types take the form:
CD11c- plasmacytoid dendritic cell is_a leukocyteCL that
has_plasma_membrane_part CD45RAPRO and
has_plasma_membrane_part CD123PRO and
has_plasma_membrane_part CD303PRO and
has_plasma_membrane_part ILT7PRO and
lacks_plasma_membrane_part CD11cPRO and
lacks_plasma_membrane_part CD3PRO and
lacks_plasma_membrane_part CD19PRO and
lacks_plasma_membrane_part CD34PRO and
lacks_plasma_membrane_part CD56PRO
where the subscripts indicate the ontology source for each
term. DC-CL, PRO, and GO CC are thereby linked
through the assertion of these trans-ontological relations.
Because no canonical CD11c- plasmacytoid DC expresses
CD11c on its cell surface, our definition correspondingly
includes the assertion: lacks_plasma_membrane_part
CD11c. On the other hand, because some CD11c- plasma-
cytoid DCs will express CCR7 on their surface while oth-
ers will not, a lacks_plasma_membrane_part CCR7 assertion
is not valid for DCs of this type, and neither is a
has_plasma_membrane_part CCR7 assertion. The negation
of the has_plasma_membrane_part CCR7 assertion is valid
in this case, however, and we are exploring the issue of
whether assertions of this sort could be useful for the con-
struction of defined classes, collections of cells that do not
constitute distinct types yet are identifiable as a group as a
consequence of common but not defining characteristics
[26]. For example, two defined classes of plasmacytoid
DCs might be distinguished, those that do and those that
do not express CCR7 on their respective membranes.
Defining cell types by differences in protein expression levels
For some cell types, including DCs, specification of the
level of protein expression is necessary for defining the cell
type [23,27,28]. Cell types are said to express low or high
levels of a protein, the salient amount being relative to the
distribution of expression levels among a defined refer-
ence population of cells. The relevant reference popula-
tion of cells is selected on the basis of the cells' possession
of certain physical characteristics, such as a particular size
and shape or pattern of surface marker expression. In flow
cytometry experiments, measurements of forward angle
and orthogonal (side) light scatter are used as surrogate
measures of cell size and organelle complexity. The rele-
vant population of cells can be defined by forward and
side scatter parameters alone, or by using these parameters
in conjunction with the expression level of surface pro-
teins additional to the protein of interest.
In the analysis of flow cytometry data, the populations of
cells used to generate the reference distribution of expres-
sion levels are defined specifically for the context of each
experiment. To define cell types ontologically, we select a
fixed cell type and refer to the distribution of expression
levels among instances of the type in our definition of
relations and cell types. For each cell type definition, we
select this reference cell type, CR, such that the cell type
definition referring to CR holds even when instances of the
cell type are identified in a particular experiment by pro-
tein expression levels relative to a different (i.e. morePage 7 of 19
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plasmacytoid DCs express low levels of CD11c relative to
leukocytes and are defined this way in DC-CL. In flow
cytometry experiments, however, such cells are frequently
analyzed in reference to a restricted population of leuko-
cytes from which T cells and NK T cells have been
removed.
To include levels of expression in the definition of cell
types in DC-CL, we define the two tertiary relations
has_high_amount(X, Y, CR) and has_low_amount(X, Y, CR)
that allow us to assert, for example, that entities of type X
contain a high amount of Y, where 'high' is defined rela-
tive to the distribution of expression levels of Y among
entities of type CR. These relations will be used to make a
series of assertions about the amount of protein Y
expressed by cell type X relative to the amount of protein
Y expressed by a reference cell type CR. Such assertions are
needed for example to distinguish conventional DCs
(CD11c high), CD11c low plasmacytoid DCs, and CD11c
negative plasmatcytoid DCs.
To define these relations, we first define the functional
operators geometric_mean_of and number_of. The first is
defined in the usual way, as a function from a set of num-
bers to their geometric mean [29]. number_of(x, Y, R, t) is
defined as the number of instances of type Y that are
related to x, an instance of X, by the relation R at time t.
Thus for example where R is the relation has_ part, this
results in:
number_of(x, Y, has_ part, t) = def the number of
instances y of Y at time t such that x has_part y at t
This defines a functional mapping, which yields, for a
given cell instance x and time t, the number of entities of
a given type Y (for example: number of instances of a cer-
tain type of molecule) which are part of that cell at that
time.
Using these functional operators, we can define
has_high_amount as follows:
has_high_amount (X, Y, Z) = def for all x and all times t, if
x instance_of X at t, then there exist some y, y' and z, such
that:
y instance_of Y at t
y' instance_of Y at t
z instance_of Z at t
x has_part y at t
z has_part y' at t,
number_of(x, Y, has_part, t)
> geometric_mean_of({number_of(z, Y, has_part, t) : z
instance_of Z at t})
where Z is a reference cell type, as defined above.
Thus, has_high_amount(X, Y, Z) asserts that, for each
instance x of X and for all times at which x is an instance
of X, there exist instances y of Y that are part of x, and that
the number of such instances y is greater than the geomet-
ric mean number of instances that are part of an instance
of Z, the reference cell type. has_low_amount(X, Y, Z) is
similarly defined, substituting the less than (<) relation
for the greater than (>) relation. In the context of DC-CL,
X and Z are cell types, y is a protein or protein complex,
and Y is the corresponding molecule type.
To specify relative amounts of surface expression, we
define
has_high_plasma_membrane_amount(X, Y, Z)
has_low_plasma_membrane_amount(X, Y, Z)
as above, but using has_plasma_membrane_part in place
of has_part in the specification of the relevant number_of
operators.
In DC-CL, we use leukocyte as common reference cell type,
so that the expression levels of a particular molecule on
DC subtypes are relative to the distribution of expression
levels of that molecule on leukocytes. For convenience, we
define
has_high_plasma_membrane_amount_relative_to_leukocyte(
X, Y) as has_high_plasma_membrane_amount(X, Y, leuko-
cyte), and similarly X has_low_plasma_membrane_
amount_relative_to_leukocyte Y.
As an example of a DC-CL definition using the
has_high_plasma_membrane_amount_relative_to_leukocyte
relation, consider the definition of dermal DCs as having
as part CD11b and CD205 (i.e. being CD11b positive and
CD205 positive; CD11b+ CD205+), having high amounts
of CD11c (CD11chigh), and lacking CD8α (CD8α-):
dermal dendritic cellDC-CL is_a leukocyteCL that
has_plasma_membrane_part CD11bPRO and
has_plasma_membrane_part CD205PRO andPage 8 of 19
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te CD11cPRO and
lacks_plasma_membrane_part CD8α homodimerGO CC
To assess whether the geometric mean represents an
appropriate threshold to distinguish high and low
expressing cells, we analyzed histograms of fluorescence
intensities for CD11c, CD11b, CD45R, CD80, CD86, and
MHC II under the assumption that the number of mole-
cules of the relevant type on the cell surface is correlated
with the fluorescence intensity after staining for the mol-
ecule of interest. Spleens were removed from untreated
mice, erythrocytes were lysed, and the cells were incu-
bated with the appropriate fluorescence-labeled antibody
or isotype control, as described in [30]. Histograms for
each molecule type were generated after gating on appro-
priate forward and side scatter values to exclude dead cells
and gating on fluorescence intensity to exclude cells that
do not express the molecule of interest. For each histo-
gram, the geometric mean of fluorescence intensities was
computed and evaluated as a threshold for classifying
high versus low expressing cells (data not shown). We
found that the geometric mean computed on the fluores-
cence intensities of positive cells provides good discrimi-
nation between high and low expressing cells. While a
formal analysis of the utility of the geometric mean of flu-
orescence intensities for the classification of cells remains
to be carried out and is beyond the scope of this paper,
this initial analysis provides support for the use of the geo-
metric mean in the definition of the relations
has_high_amount and has_low_amount.
Species specificity of DC-CL cell types
To best facilitate cross-species data interoperability, ontol-
ogies need to provide both species-neutral and species-
specific terms. Species-neutral terms allow for commonal-
ities between species to be identified. Such commonalities
can be used for the generation of hypotheses not only
about human biology from experimental results observed
in model organisms but also about basic principles, such
as those underlying cell biology or mammalian biology.
Species-specific terms are equally important, however, as
they allow for the more accurate and precise representa-
tion of information and data pertaining to organisms of
different species and thus enable us to capture more pre-
cisely the differences between such organisms.
The approach we outline for defining cell types in DC-CL
results in the systematic inclusion of both species-neutral
and species-specific terms and allows prospectively for the
systematic capture of orthology relationships between
species-specific types, where they exist. Because we define
cell types by linking to species-neutral terms in PRO and
GO CC, cells expressing the same combination of surface
proteins are instances of the same DC-CL type, regardless
of their species of origin. For example, cells that are
CD11c+ and CD19- CD3- C34- CD56- are referred to as
conventional dendritic cells in both mice and humans,
and instances of such cells in mice and in humans are
instances of the DC-CL type conventional dendritic cell. Spe-
cies-specific terms arise not because we use species of ori-
gin as a defining characteristic, but rather because the DC
types identified in mice and humans express different
combinations of surface proteins. For example, the cells
referred to as plasmacytoid dendritic cells in mice are
marked by expression of CD45R, GR1, and CD11c and
the absence of CD11b, while in humans, plasmacytoid
dendritic cells are marked by expression of CD45RA,
CD123, CD303, and ILT7. Thus, in DC-CL, we have
CD11c+ and CD11c- plasmacytoid dendritic cells, corre-
sponding to those observed in mice and humans, respec-
tively.
PRO includes multiple levels of classification for proteins,
including a gene product level, a sequence variant level
(e.g. for genetic differences), a protein isoform level (e.g.
for splice variants), and a post-translational modification
level [24,31]. PRO is species-neutral in the sense that, pro-
teins from different species that are the products of orthol-
ogous genes are instances of the same PRO gene product
level type, and proteins from different species represent-
ing equivalent forms (e.g. CD45RA in human and mouse)
are instances of the same sequence variant level or protein
isoform level types. Likewise, protein forms from different
species with equivalent post-translational modifications
are instances of the same post-translational modification
level type. The protein complex types represented in GO
CC are similarly species-neutral. Although the curation of
PRO has thus far focused on inclusion of types corre-
sponding to the protein instances observed in mice and
humans, future PRO curation efforts will ensure broader
species inclusivity.
To avoid the unnecessary creation of overly specific sub-
types, we define cell types in terms of PRO gene product
level types, and recommend that PRO types at this level be
used wherever possible. When necessary, however, repre-
sentations of more specific protein types can be used. For
example, the alternative splice forms CD45RA and
CD45RO may be needed to define some T lymphocyte
subtypes by linking to the corresponding PRO protein iso-
form level types [32].
When species-specific cell types are defined either through
the use of species-specific combinations of PRO gene
product level types or through the use of PRO types corre-
sponding to species-specific amino acid sequences, the
relationships between protein types in PRO provide the
information needed to identify cell types expressing
related proteins.Page 9 of 19
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The backbone is_a hierarchy that is used in formulating
definitions of DC-CL terms is based on the types and lev-
els of proteins expressed on the cell surface. DC-CL also
includes, however, further relations that are used in asser-
tions about the functions each of the cell types performs
and about their dispositions to participate in processes of
specific types. Assertions about functions are made by
linking terms in DC-CL to terms referring to types of func-
tions using the RO relation has_function. Similarly, asser-
tions about dispositions are made using the RO relation
has_disposition.
The terms for cellular functions and dispositions are
linked to GO biological process (GO BP) terms using the
RO relation realized_in, in axioms of the form:
X realized_in YGO BP
X realized_in YGO BP.
where Y is a process type from GO BP. For example:
antigen processing activityDC-CL realized_in antigen
processing and presentationGO BP
disposition to cross-present antigen to CD8+ T cellsDC-CL
realized_in antigen presentation, exogenous antigen via
MHC class IGO BP.
Where the representation of functions and dispositions
needed for DC-CL requires reference to a process for
which we could find no corresponding GO BP term, we
have submitted a term request to the Gene Ontology
tracker [33].
Locations
Assertions about the anatomical location of DC subtypes
are made by relating DC subtype terms to terms in the
Foundational Model of Anatomy [21], using assertions of
the form:
YFMA location_of XDC-CL
which states that every instance of the anatomical struc-
ture type Y is the location of some instance of the DC type
X. For example:
lymph nodeFMA location_of mature CD8α- CD11c- den-
dritic cellDC-CL
While this is an ontological assertion about an anatomical
entity rather than about a cell type, inclusion of assertions
of this form allows the ontology to be queried for the ana-
tomical locations in which the various DC types can be
found. They also serve to link DC-CL to other ontologies
within the OBO Foundry, and thus serve more general
networking of information in a way that provides support
for further types of reasoning.
Lineage Relationships between Cell Types
Lineage relationships between cell types are captured
using the arises_from and the transformation_of relations.
The relations arises_from, derives_from and
transformation_of are formally defined in the RO [19].
derives_from, the instance-level relation, is defined as the
relation between "distinct material continuants when one
succeeds the other across a temporal divide in such a way
that at least a biologically significant portion of the matter
of the earlier continuant is inherited by the latter" [19].
There are three types of derives_from relations, the con-
tinuation of an instance that loses a small portion of itself,
fusion, such as the fusion of a sperm and an egg to form a
zygote, and fission, such as the division of a cell to form
two daughter cells. derives_from, the class-level relation, is
the relation between classes C and C' when instances of C
are connected to instances of C' by a series of
derives_from relations [19]. transformation_of is defined
as the relation between two classes, in which "one and the
same continuant entity preserves its identity while instan-
tiating distinct classes at distinct times" [19]. That is, a sin-
gle instance is of type C at one time and of type C' at a later
time, as in the transformation from child to adult.
arises_from is the parent relation of derives_from and
transformation_of.
In DC-CL, we use transformation_of as the relation between
immature and mature cell types because we are asserting
a one-to-one relationship between instances of the types.
All other lineage relationships, such as that between
hematopoietic stem cells and common lymphoid precur-
sors, are asserted using the arises_from relation because the
relationship between instances may not be one-to-one.
Results
DC-CL cell types
Terms for 29 DC types are defined in DC-CL, along with
12 precursor cell types, which are defined in order to
assert lineage relationships. All DC types are subtypes of
conventional dendritic cell, CD11clow plasmacytoid dendritic
cell, or CD11c- plasmacytoid dendritic cell (Table 1).
The type conventional dendritic cell has 22 subtypes identi-
fied in the current version of DC-CL; CD11clow plasmacytoid
dendritic cell and CD11c- plasmacytoid dendritic cell each
have 2 subtypes. The surface protein combinations that
define these subtypes are shown in Tables 2 and 3, respec-
tively; the placement of these types in the DC-CL hierar-
chy is shown in Figure 2.Page 10 of 19
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therefore not placed in the DC-CL hierarchy. We define
them for completeness, however, in order to provide sur-
face protein-based definitions for all cell types referred to
in DC-CL assertions. The surface protein combinations
that define the 12 precursor types are shown in Tables 4
and 5.
In addition to defining the DC types by the presence or
absence of specific surface proteins, we include assertions
about which of the Toll-like receptors (TLR) are expressed
on each DC type. Future work on DC-CL will include
incorporation of assertions about other molecules impor-
tant to immune function, such as additional pattern rec-
ognition receptors and cytokine receptors.
Functions and Dispositions
The DC types in DC-CL are related to functions (Table 6)
and dispositions (Table 7) using the has_function and
has_disposition relations. The six plasmacytoid dendritic
cell types all share a common disposition to secrete type 1
interferon. Additional functions and dispositions for the
subtypes of conventional dendritic cell and for the plasma-
cytoid dendritic cell subtypes are shown in Tables 8, 9 and
10.
Assertions in DC-CL are associated with reference to at
least one journal article via PubMed ID.
Discussion
We present here an ontology of DC types (DC-CL) and the
method used to create the ontology. The motivation for
developing DC-CL was two-fold: to provide a common
point of reference for standardized terms and definitions
for DC subtypes and to develop a method for representing
cell types that is highly computable and builds on existing
resources. DCs have a particularly complicated biology
[16-18]; thus not only are efforts to develop standardized,
comprehensive information resources needed, but DCs
are a good model for testing a method for representing
cells in an ontology.
We have developed DC-CL using a systematic approach
for the ontological representation of cells that:
i) separates classification via the is_a relation from the
assertion of structural, functional, and lineage properties
by using formally defined, property-specific relations,
such as has_function
ii) systematically includes both species-neutral and spe-
cies-specific types
iii) defines cell types on the basis of specific combinations
of surface proteins used for identification of the cells via
flow cytometry.
Table 1: The genus-differentia form of the definitions for the three most general types in DC-CL.
DC-CL Term Genus Differentia
conventional dendritic cell leukocyteCL has_high_plasma_membrane_amount CD11cPRO
lacks_plasma_membrane_part CD3PRO
lacks_plasma_membrane_part CD19PRO
lacks_plasma_membrane_part CD34PRO
lacks_plasma_membrane_part CD56PRO
CD11clow
plasmacytoid dendritic cell leukocyteCL has_low_plasma_membrane_amount CD11cPRO
has_plasma_membrane_part CD45RPRO
has_plasma_membrane_part GR1PRO
lacks_plasma_membrane_part CD11bPRO
lacks_plasma_membrane_part CD3PRO
lacks_plasma_membrane_part CD19PRO
lacks_plasma_membrane_part CD34PRO
lacks_plasma_membrane_part CD56PRO
CD11c-
plasmacytoid dendritic cell leukocyteCL has_plasma_membrane_part CD45RAPRO
has_plasma_membrane_part CD123PRO
has_plasma_membrane_part CD303PRO
has_plasma_membrane_part ILT7PRO
lacks_plasma_membrane_part CD11cPRO
lacks_plasma_membrane_part CD3PRO
lacks_plasma_membrane_part CD19PRO
lacks_plasma_membrane_part CD34PRO
lacks_plasma_membrane_part CD56PROPage 11 of 19
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to incorporate structural, functional, and lineage proper-
ties has many benefits. First, this approach eliminates
many of the errors that frequently result from multiple
uses of the is_a relation [34-36] in what has been called
'is_a overloading' [15]. Second, the is_a relation can only
be used between entities of the same ontological category
(higher level types, such as those found in the Basic For-
mal Ontology described below), while specific relations
can be used to relate cells to entities in other categories,
such as functions (has_function), molecules (has_part),
and processes (participates_in), that are represented within
their own ontologies. DC-CL is formally connected to the
hierarchical structure and relations of these ontologies, as
well as the data annotated in their terms, thereby provid-
ing significant additional information and opportunities
for data integration. The use of property-specific relations
also allows us, without sacrificing expressive power, to
Table 2: Surface protein combinations defining the subtypes of conventional dendritic cell.
205 11b 4 8α 1a 206 209 36 14 207 324 80 83 86 MHC
II
CD8α-CD11b- DC + - - -
immature + - - - L L L
CD8α-CD11b- DC
mature + - - - H + H H
CD8α-CD11b- DC
CD8α- CD11b+ DC - + + -
immature - + + - L L L
CD8α- CD11b+ DC
mature - + + - H + H H
CD8α- CD11b+ DC
CD8α + CD11b- DC + - - +
immature + - - + L L L
CD8α + CD11b- DC
mature + - - + H + H H
CD8α + CD11b- DC
interstitial DC + + + +
immature + + + + L L L
interstitial DC
mature + + + + H + H H
interstitial DC
Langerhans cell +
CD1a+ Langerhans cell + + +
immature CD1a+ + + + L L L
Langerhans cell
mature CD1a+ + + + H + H H
Langerhans cell
CD8αlow Langerhans cell H L +
immature CD8αlow H L + L L L
Langerhans cell
mature CD8αlow H L + H + H H
Langerhans cell
dermal DC + + -
immature dermal DC + + - L L L
mature dermal DC + + - H + H H
Column headings show protein or protein complex names. Numbers correspond to CD antigens (e.g. CD205 is referred to as 205 in the table). 
Row labels show the terms for subtypes of conventional dendritic cell defined in DC-CL. Row labels not indented correspond to direct subtypes of 
conventional dendritic cell; indented row labels correspond to direct subtypes of the types referred to by the nearest, above row with less indent. + 
indicates that the has_plasma_membrane_part relation is use to join the cell type term to the protein or protein complex term; – indicates that the 
lacks_plasma_membrane_part relation is used; L indicates that the has_low_plasma_membrane_amount relation is used; and H indicates that the 
has_high_plasma_membrane_amount relation is used.Page 12 of 19
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tional unit in the ontology has maximally one single
asserted is_a parent), which brings benefits such as clearer
statement of definitions, easier and more reliable cura-
tion, ability to use more powerful reasoning tools, and the
ability to have a unique measure of distance between any
two terms on the same branch of an ontology. Finally, the
use of property-specific relations enhances ontologies for
computational analyses because each relation can be
defined with its own inference properties.
The inclusion of species-specific cell types allows for the
more specific annotation of data and for the incorpora-
tion within DC-CL of species-specific properties, many of
which have important functional consequences. For
example, the plasmacytoid DCs observed in humans
(CD11c-) express Toll-like receptors (TLR) TLR7 and
TLR9, while the plasmacytoid DCs observed in mice
(CD11clow) express all mouse TLRs except for TLR3 and
TLR4, with consequent differences in the types of patho-
gens human and mouse plasmacytoid DCs can detect
[37]. We avoid use of species of origin as a basis of defin-
ing types, however, and only define types based on the
presence or absence of specific surface proteins. Thus, the
plasmacytoid DCs observed in humans are instances of
the type CD11c- plasmacytoid dendritic cell, while the plas-
macytoid DCs observed in mice are instances of the type
CD11clow plasmacytoid dendritic cell, where the two types are
defined by the patterns of surface protein expression given
in the above definitions. Plasmacytoid DCs observed in a
third species to have either pattern of surface protein
expression would be instances of the corresponding type.
In addition, we only include assertions about the cell
types that hold across all species in which the type is
observed. In this way, the inclusion of species-specific DC
types in DC-CL facilitates understanding of the similari-
ties and differences between mouse and human immu-
nology and improved capacity for generating hypotheses
about the human immune response from the interpreta-
tion of the results of mouse experiments. In this way DC-
CL also fosters the advance of translational medicine.
To define cell types on the basis of species of origin, or to
include assertions that hold for the type in one species but
not another, we recommend the creation of species-spe-
cific extensions rather than the inclusion of such types in
CL or DC-CL. This approach allows for the representation
of detailed, species-specific information without using
multiple modes of classification (structure and species of
origin) or including conflicting assertions in the core
ontology. The approach of more specific extensions of a
core template ontology has been used successfully in the
creation of species-specific anatomy ontologies as exten-
sions of the Common Anatomy Reference Ontology
(CARO) [38] and in the creation of ontologies of specific
infectious diseases as extensions of the core Infectious
Disease Ontology (IDO) [39].
The use of specific combinations of surface proteins to
define DC subtypes has advantages both for the creation
of DC-CL and for its application to the analysis of cellular
data. A primary means by which experimentalists distin-
guish cell types is by distinguishing patterns of protein
expression using flow cytometry. Defining DC subtypes in
Table 3: Surface protein combinations defining the subtypes of CD11c- plasmacytoid dendritic cell and CD11clow plasmacytoid dendritic 
cell.
123 303 ILT7 45RA 45R GR1 11c 11b 80 83 86 MHC
II
immature CD11c- plasmacytoid DC + + + + - - L L
mature CD11c- plasmacytoid DC + + + + - H + H H
immature CD11clow plasmacytoid DC + + L - L L
mature CD11clow plasmacytoid DC + + L - H + H H
Other details are as in Table 2.
Table 4: Surface protein combinations used to define DC precursors in DC-CL.
7 45RA 4 3, 19 34 123 10 71 133 33 2, 11b, 15, 56 16 11c 31 32 43 86
CD7- lymphoid precursor - - - - +
CD7+ lymphoid precursor + - - - +
granulocyte-monocyte precursor + - - + +
CD10+ common lymphoid precursor + + - - + +
CD71+ common myeloid precursor - + - - + - +
CD133+ hematopoietic stem cell - + - + - - -
CD43+ monocyte + + + + + +
Other details as in Table 2.Page 13 of 19
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CL of new discoveries about DCs deriving from experi-
ments involving flow cytometry to isolate or analyze cell
populations. Similarly, defining DC subtypes in terms of
flow markers optimizes DC-CL for the annotation, analy-
sis, and integration of flow cytometry data and of data
deriving from experiments in which fluorescence-acti-
vated cell sorting is used as a source of cells. Just as the
Gene Ontology has been shown to offer significant bene-
fits for the computational analysis of high-throughput
data in the study of gene expression using hybridization
microarrays [8], we anticipate similar benefits from the
use of an ontology of cell types to support analysis of
high-throughput, multidimensional flow data.
The relations has_high_amount and has_low_amount
defined in terms of the geometric mean are used in the
definition of cell types and are not meant to replace more
complicated statistical methods for the analysis of flow
cytometry data, such as is described in [40], or other cel-
lular data. Such statistical methods can be applied to the
analysis of individual flow data sets, while ontology defi-
nitions need to hold universally, across different experi-
mental designs, protocols, and equipment and across
differences in the resulting distributions of fluorescence
intensities for reference cells. Indeed, the ontology defini-
tions should hold across different assays for surface pro-
tein expression, and should not be tied directly to flow
cytometry. We have therefore taken a relatively simple
approach to the formulation of cell definitions that hold
universally and that are supported by our current under-
standing of DC biology. It is our hope, however, that our
work, taken together with [40], will encourage the use of
more objective criteria in the analysis of flow cytometry
data and in the description and analysis of cell types in
general.
The classification of DCs is still an area of active research,
thus DC-CL will continue to undergo revisions to keep
current with new research results and new technologies
for the characterization of cell types [28]. Because ontolo-
gies are based on an open world assumption, in contrast
to relational databases, they are easily extended to include
new subcategories. In addition, the formulation of DC-CL
definitions as logically conjoined statements of the from
XRY makes it easy to add or remove surface proteins from
Table 7: DC-CL disposition terms and their corresponding GO-BP terms.
DC-CL Disposition Term GO BP Process Term
disposition to circulate in the blood
disposition to cross-present antigen to CD8+ T cells antigen presentation, exogenous antigen via MHC class I
disposition to migrate to the lymph node leukocyte migration
disposition to secrete anti-inflammatory cytokines
disposition to secrete inflammatory cytokines
disposition to secrete type 1 interferon
Table 6: DC-CL function terms and their corresponding GO BP process terms.
DC-CL Function Term GO BP Process Term
antigen capture activity
antigen processing activity dendritic cell antigen processing and presentation
antigen presentation activity dendritic cell antigen processing and presentation
antigen transportation activity
cytokine secretion activity cytokine secretion
Table 5: Surface protein combinations used to define DC precursors in DC-CL.
117 16 135 M- CSFR 217 SCA1 2, 3, 4, 5, 8, 45R, GR1, NK1.1, Ter-
119
32 34 90 115 11b
common dendritic precursor + + +
CD217+ common lymphoid 
precursor
+ + + -
CD117+ common myeloid precursor + + - - - + +
SCA1+ hematopoietic stem cell + + - - -
CD115+ monocyte + +
Other details as in Table 2.Page 14 of 19
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assess consequences of the revision on the DC-CL hierar-
chy. Thus, newly discovered surface markers can be easily
incorporated into the ontology. Furthermore, the system
we have outlined is readily applicable to subcellular local-
izations other than the cell surface and to other cellular
components such as mRNA molecules or cytoplasmic
granules. In addition to defining more localization-spe-
cific relations like has_plasma_membrane_part, the general
RO relations has_part and lacks can be used. For all of
these relations, too, cellular components other than pro-
teins and protein complexes can be used as arguments.
Table 8: Functions of each conventional DC subtype.
antigen processing 
activity
cytokine secretion 
activity
macro- pinocytosis 
activity
T cell antigen 
presentation activity
antigen transportation 
activity
CD8α-CD11b- DC + +
immature + + + + +
CD8α-CD11b- DC
mature + +
CD8α-CD11b- DC
CD8α- CD11b+ DC + +
immature + + + + +
CD8α- CD11b+ 
DC
mature + +
CD8α- CD11b+ 
DC
CD8α + CD11b- DC + +
immature + + + + +
CD8α + CD11b- 
DC
mature + +
CD8α + CD11b- 
DC
interstitial DC + +
immature + + + + +
interstitial DC
mature + +
interstitial DC
Langerhans cell + +
CD1a+ Langerhans 
cell
+ +
immature 
CD1a+
+ + + + +
Langerhans cell
mature CD1a+ + +
Langerhans cell
CD8αlow 
Langerhans cell
+ +
immature 
CD8αlow
+ + + + +
Langerhans cell
mature 
CD8αlow
+ +
Langerhans cell
dermal DC + +
immature dermal 
DC
+ + + + +
mature dermal DC + +
+ indicates that the cell type referred to by the row label is related to the function indicated by the column heading using the has_function relation.Page 15 of 19
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also be used to define cell types using the has_quality rela-
tion to link to the relevant qualities in PATO, the ontology
of phenotypic qualities [41]. In this way, the DC-CL
framework lends itself quite readily to the incorporation
of new information as knowledge of DC biology
increases.
We have built our representations of cell types in DC-CL
by relating terms in the domains covered by the OBO
Foundry ontologies using relations from the Foundry's
relation ontology (RO) and creating new relations as
needed. The OBO Foundry [6] was created in 2006 by a
group of developers of OBO ontologies on the basis of an
evolving set of principles designed to foster the pursuit of
best practice in ontology development [13]. Its ontologies
are designed to represent in an interoperable fashion the
biomedical reality from which data are sampled. Their
development within the framework of a common top-
level ontology (Basic Formal Ontology, BFO, [42]) and
consistent employment of a common set of relations
allows Foundry ontologies to be used together as modules
of a larger system.
There are many benefits to building DC-CL from OBO
Foundry ontologies. In addition to the formalism under-
lying Foundry ontologies ensuring their support for
sophisticated computation both within and between
ontologies, building from Foundry ontologies means
extensive use of existing ontology resources, both elimi-
nating redundant effort and providing a significant head-
start to ontology development. By building on OBO
Foundry ontologies, DC-CL is automatically interopera-
ble with other ontologies that also build from Foundry
ontologies and with the large information resources, such
as UniProt, that use Foundry ontologies for their annota-
tions, representing a wide base of existing annotations.
Finally, as OBO Foundry ontologies, and in particular
GO, are widely used, use of Foundry ontologies in con-
structing DC-CL improves the chances that DC-CL will be
accepted by the biological ontology and database com-
munities.
DC-CL will serve as a valuable information resource not
only providing centralized access to existing information
about DCs, but also providing standardized representa-
tions that allow algorithmic processing for data analysis
and the testing of hypotheses. The consistent use of for-
mally defined relations means that reasoners, such as
those included in ontology editing software like OBO-
Edit and Protégé, can be reliably applied to DC-CL. In
addition, representing information in DC-CL in the from
of XRY statements, rather than in natural language defini-
tions, means that DC-CL can be easily parsed, facilitating
the implementation of custom algorithms for querying
DC-CL or analyzing data annotated in its terms. For exam-
ple, DC-CL can be queried for the list of proteins
expressed by a certain cell type, for the list of cells that
express a particular combination of proteins, or for the
types of cells that participate in a particular process or
have a particular function. We are currently working to
integrate DC-CL into software designed for the analysis of
flow cytometry data and to assess the ways in which the
use of DC-CL can enhance flow data analysis.
Conclusion
DC-CL provides a prospectively highly valuable resource
for the study of DCs. It further offers a generalizable
method for the ontological representation of cells that
offers significant benefits in the form of increasing the
amount and accuracy of information contained in the
ontology, enhancing support of the ontology for compu-
tation, and providing a much needed resource to support
analysis of high-throughput, multidimensional flow data.
Thus, we propose the method used to create DC-CL as a
strategy for the representation of all cells of hematopoietic
lineage.
Abbreviations
CL: Cell Ontology; DC-CL: Ontology of Dendritic Cell
Types; DC: dendritic cells; RO: Relation Ontology; PRO:
Table 9: Functions of each plasmacytoid DC subtype.
antigen processing 
activity
cytokine secretion 
activity
macro- pinocytosis 
activity
T cell antigen 
presentation activity
antigen transportation 
activity
immature CD11c- + + + + +
plasmacytoid DC
mature CD11c- + +
plasmacytoid DC
immature CD11clow + + + + +
plasmacytoid DC
mature CD11clow + +
plasmacytoid DC
Other details as in Table 7.Page 16 of 19
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disposition to 
circulate in the 
blood
disposition to 
cross-present 
antigen to CD8+ T 
cells
disposition to 
migrate to the 
lymph node
disposition to 
secrete anti- 
inflammatory 
cytokines
disposition to 
secrete 
inflammatory 
cytokines
disposition to 
secrete type 1 
interferon
CD8α-CD11b- 
DC
immature
CD8α-CD11b-
DC
mature +
CD8α-CD11b-
DC
CD8α- CD11b+ 
DC
+
immature +
CD8α- 
CD11b+DC
mature +
CD8α- 
CD11b+DC
CD8α + CD11b-
DC
+ +
immature + +
CD8α + 
CD11b-DC
mature + +
CD8α + 
CD11b-DC
interstitial DC
immature +
interstitial DC
mature
interstitial DC
Langerhans cell
CD1a+
Langerhans cell
immature +
CD1a+
Langerhans 
cell
mature
CD1a+
Langerhans 
cell
CD8αlow + +
Langerhans cell
immature + +
CD8αlow
Langerhans 
cell
mature + +
CD8αlow
Langerhans 
cell
dermal DC
immature +Page 17 of 19
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ponent Ontology; CD8α+: possession of CD8α molecules
on the cell surface (similar notation is used for other mol-
ecules); CD8α-: absence of CD8α molecules on the cell
surface (similar notation is used for other molecules);
CD11chigh: high levels of CD11c molecules on the cell sur-
face (similar notation is used for other molecules);
CD11clow: low levels of CD11c molecules on the cell sur-
face (similar notation is used for other molecules); TLR:
toll-like receptor; CARO: Common Anatomy Reference
Ontology; IDO: Infectious Disease Ontology; BFO: Basic
Formal Ontology; DC-KB: Dendritic Cell Knowledge Base.
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